Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.-
-
-
-
-
-
-
Diagnostic company Exact Sciences to buy Genomic Health in $2.8 billion deal
-
-
-
-
-
-
-
Novartis hints at 2018 outlook hike despite drug price freeze
-
-
-
-
-
-
-
Pre-Open Movers 02/21: (EYEG) (CYH) (PLKI) Higher; (TRVN) (MNTA) (UL) Lower (more...)
-
-
-
-
-
-
-
Allergen's (AGN) Price Target Reduced to $282 at Deutsche Bank
-
-
-
-
-
-
-
Pre-Open Stock Movers 02/05: (HSP) (EOPN) (DATA) (TWTR) Higher; (QUIK) (ADEP) (IRBT) Lower (more...)
-
-
-
-
-
-
-
Notable Analyst Rating Changes 05/27: (CSCO) (SPLK) (ODP) Upgraded; (SPLS) (PCYC) (AZN) Downgraded
-
-
-
-
-
-
-
StreetInsider.com Pre-Open Movers 6/12: (CTB) (CYTK) (HMA) Higher; (CLSN) (FSLR) (IEP) Lower (more...)
-
47,736 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All